13F Holdings
中文EN

XLAB Exascale Labs Holdings Inc.

Services-Prepackaged Software · Nasdaq · SEC CIK 2109869 · Fiscal year ends 06/30

Financial factors as of 2026-06-30 (FY2026), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY111.3%
TTM net income YoY-58.8%
TTM EPS YoY-58.8%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin16.3%
Operating margin-32.4%
Net margin-82.1%
FCF margin—
EBITDA margin-32.3%

Returns

ROE—
ROA-173.1%
ROIC (approx.)—
Asset turnover2.11x

Leverage & solvency

Liabilities / assets474.0%
Debt / equity—
Current ratio0.20x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.23x
Accruals ratio-133.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-06-30FY20252025-06-30
Income statement
Revenue$14.82M$7.02M
Cost of revenue$12.40M$5.91M
Gross profit$2.42M$1.11M
R&D expense$5.49M$2.80M
SG&A expense$1.23M$362,982
Operating income-$4.80M-$3.04M
Pretax income-$12.16M-$7.66M
Net income-$12.16M-$7.66M
EBITDA-$4.79M-$3.04M
EPS (basic)-8,108.26-5,106.44
EPS (diluted)-8,108.26-5,106.44
Weighted avg. shares (diluted)1,5001,500
Balance sheet
Cash & equivalents$2.69M$4.23M
Receivables$1.15M$152,536
Current assets$6.52M$7.30M
PP&E, net$12,840$19,600
Total assets$6.73M$7.32M
Current liabilities$31.89M$20.32M
Total liabilities$31.89M$20.32M
Shareholders' equity-$25.16M-$13.00M
Shares outstanding—1,500
Cash flow statement
Operating cash flow-$2.75M-$1.01M
Capital expenditure—$2,138
Free cash flow—-$1.01M
Investing cash flow$1.41M-$2,138
Financing cash flow-$190,000$4.28M
Depreciation & amortization$6,760$6,234
Stock-based compensation$0$153,266

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.